86129-92-2 Usage
General Description
1-tert-butyl-3,3-diphenyl-4-(2-phenylethenyl)azetidin-2-one is a chemical compound with the molecular formula C28H27NO. It is a azetidinone derivative with a tert-butyl group, diphenyl groups, and a phenylethenyl substituent attached to the azetidinone ring. 1-tert-butyl-3,3-diphenyl-4-(2-phenylethenyl)azetidin-2-one has potential pharmaceutical applications due to its ability to act as an inhibitor for certain enzymes and receptors, making it a target for drug development in areas such as oncology and neuroscience. It also exhibits anti-inflammatory and antioxidant properties, which could be beneficial for therapeutic purposes. Additionally, 1-tert-butyl-3,3-diphenyl-4-(2-phenylethenyl)azetidin-2-one has been studied for its potential use in synthetic organic chemistry, serving as a building block for the synthesis of other bioactive molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 86129-92-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,6,1,2 and 9 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 86129-92:
(7*8)+(6*6)+(5*1)+(4*2)+(3*9)+(2*9)+(1*2)=152
152 % 10 = 2
So 86129-92-2 is a valid CAS Registry Number.
86129-92-2Relevant academic research and scientific papers
Halogenated Ketenes. 38. Cycloaddition of α,β-Unsaturated Imines with Ketenes To Yield Both β- and δ-Lactams
Brady, William T.,Shieh, C. H.
, p. 2499 - 2502 (2007/10/02)
The cycloaddition of various types of α,β-unsaturated imines with diphenyl- and dichloroketenes yields both (2 + 2) and (4 + 2) cycloaddition products, i. e., β-lactams and δ-lactams, respectively.The cycloaddition products are dependent upon substitution in the imine and the ketene.The δ-lactams derived from dichloroketene are easily dehydrochlorinated to the corresponding 2-pyridones.All of the results are consistent with a two-step cycloaddition process involving a dipolar intermediate.